Effects of maternal commercial supplementation on 25-hydroxyvitamin D levels in newborns: a retrospective cohort study in a single center, Saitama, Japan, 2022–2023
Endocrine Journal · 2026
DOI: 10.1507/endocrj.ej25-0266 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Endocrine Journal, 2026. Verfasst von Kazumi Morisawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Vitamin D Deficiency, Pregnancy Complications. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
- Division of Neonatology, Department of Pediatrics, Saitama City Hospital, Saitama 336-8522, Japan.
Zitieren
APA
Morisawa, K., Ikeda, K., Hida, M., & Hara-Isono, K. (2026). Effects of maternal commercial supplementation on 25-hydroxyvitamin D levels in newborns: a retrospective cohort study in a single center, Saitama, Japan, 2022–2023. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0266
Vancouver
Morisawa K, Ikeda K, Hida M, Hara-Isono K. Effects of maternal commercial supplementation on 25-hydroxyvitamin D levels in newborns: a retrospective cohort study in a single center, Saitama, Japan, 2022–2023. Endocrine Journal. 2026. doi:10.1507/endocrj.ej25-0266
BibTeX
@article{Morisawa2026,
author = {Morisawa, Kazumi and Ikeda, Kazushige and Hida, Mariko and Hara-Isono, Kaori},
title = {Effects of maternal commercial supplementation on 25-hydroxyvitamin D levels in newborns: a retrospective cohort study in a single center, Saitama, Japan, 2022–2023},
journal = {Endocrine Journal},
year = {2026},
doi = {10.1507/endocrj.ej25-0266}
}
EUVIMED